Massachusetts Financial Services
CBAY

Massachusetts Financial Services’s Cymabay Therapeutics CBAY Stock Holding History

Massachusetts Financial Services’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-196,052
Closed -$663K – 916
2021
Q4 		$663K Sell
196,052
-41,721
-18% -$158K ﹤0.01% 840
2021
Q3 		$868K Sell
237,773
-3,121
-1% -$12.3K ﹤0.01% 841
2021
Q2 		$1.05M Buy
240,894
+2,070
+0.9% +$9.18K ﹤0.01% 836
2021
Q1 		$1.08M Buy
238,824
+91,471
+62% +$492K ﹤0.01% 830
2020
Q4 		$846K Buy
+147,353
New +$1.12M ﹤0.01% 806

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Massachusetts Financial Services's CBAY Position: Q1 2022 in Review

Massachusetts Financial Services sold out of Cymabay Therapeutics (CBAY) in Q1 2022, closing a stake of 196,052 shares — an estimated $663K sold.

Massachusetts Financial Services first reported a position in CBAY in Q4 2020 and held it in 5 quarters. The position peaked at $1.08M in Q1 2021. 118 funds tracked by Wall St. Rank hold CBAY as of Q1 2022.

  • Massachusetts Financial Services reported no remaining Cymabay Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Massachusetts Financial Services sold 196,052 Cymabay Therapeutics shares in Q1 2022, an estimated $663K.
  • Massachusetts Financial Services first reported a position in Cymabay Therapeutics in Q4 2020 and held it in 5 quarters.
  • Massachusetts Financial Services's Cymabay Therapeutics position peaked at $1.08M in Q1 2021.
  • 118 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2022.

Based on Massachusetts Financial Services's 13F filing for Q1 2022, filed 11 May 2022.